These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 11436104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.
    Fernández-Jiménez MC, Canales MA, Ojeda E, de Bustos JG, Aguado MJ, Hernández-Navarro F.
    Haematologica; 1999 Nov; 84(11):1007-11. PubMed ID: 10553161
    [Abstract] [Full Text] [Related]

  • 4. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 5. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
    Motzer RJ, Gulati SC, Tong WP, Menendez-Botet C, Lyn P, Mazumdar M, Vlamis V, Lin S, Bosl GJ.
    Cancer Res; 1993 Aug 15; 53(16):3730-5. PubMed ID: 8393380
    [Abstract] [Full Text] [Related]

  • 6. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R.
    N Engl J Med; 2007 Jul 26; 357(4):340-8. PubMed ID: 17652649
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
    Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S.
    Biol Blood Marrow Transplant; 2005 Nov 26; 11(11):903-11. PubMed ID: 16275593
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ.
    Semin Oncol; 1998 Apr 26; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [Abstract] [Full Text] [Related]

  • 10. Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
    Broun ER, Nichols CR, Mandanas R, Salzman D, Turns M, Hromas R, Cornetta K, Einhorn LH.
    Bone Marrow Transplant; 1995 Sep 26; 16(3):353-8. PubMed ID: 8535306
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors.
    Mandanas RA, Saez RA, Epstein RB, Confer DL, Selby GB.
    Bone Marrow Transplant; 1998 Mar 26; 21(6):569-76. PubMed ID: 9543060
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin.
    Stein RS, Greer JP, Goodman S, Kallianpur A, Ahmed MS, Wolff SN.
    Bone Marrow Transplant; 1999 Feb 26; 23(3):227-33. PubMed ID: 10084253
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL, Fadel E, Ibrahim A, Bourhis JH, Droz JP.
    Bull Cancer; 1995 Feb 26; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [Abstract] [Full Text] [Related]

  • 17. [Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].
    Baume D, Pico JL, Droz JP, Ostronoff M, Azab M, Gilles E, Ghosn M, Salloum E, Gouyette A, Beaujean F.
    Bull Cancer; 1990 Feb 26; 77(2):169-80. PubMed ID: 2156588
    [Abstract] [Full Text] [Related]

  • 18. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M.
    Bone Marrow Transplant; 2002 Dec 26; 30(12):885-91. PubMed ID: 12476281
    [Abstract] [Full Text] [Related]

  • 19. Progressive disease after ABMT for Hodgkin's disease.
    Bolwell BJ, Kalaycio M, Goormastic M, Dannley R, Andresen SW, Lichtin A, Overmoyer B, Pohlman B.
    Bone Marrow Transplant; 1997 Nov 26; 20(9):761-5. PubMed ID: 9384478
    [Abstract] [Full Text] [Related]

  • 20. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD, Skarin AT, Richardson P, Ibrahim J, McCauley M, Frei E.
    Biol Blood Marrow Transplant; 2002 Nov 26; 8(6):326-33. PubMed ID: 12108918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.